INVO's free cash flow for Q2 2023 was $-1.91M. For the 2023 fiscal year, INVO's free cash flow was decreased by $-131.48K and operating cash flow was $-1.64M. See a summary of the company’s cash flow.

Cash Flow	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Operating Cash Flow	$ -5.45M	$ -6.60M	$ -6.03M	$ -4.78M	$ 1.37M	$ -652.97K
Investing Cash Flow	$ -264.38K	$ -81.22K	$ -2.15M	$ -187.25K	$ -114.71K	$ -19.40K
Financing Cash Flow	$ 3.86M	$ 1.09M	$ 3.77M	$ 13.82M	$ -229.47K	$ 858.86K
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 2.68M	$ 90.14K	$ 5.68M	$ 10.10M	$ 1.24M	$ 212.24K
Income Tax Paid Supplemental Data	$ -2.05K	$ 800.00	$ 3.31K	$ 1.06K	$ 912.00	$ 912.00
Interest Paid Supplemental Data	$ 5.72K	-	$ 52.60K	$ 253.39K	$ 84.04K	$ 6.07K
Issuance Of Capital Stock	$ 2.67M	$ 300.00K	$ 3.65M	$ 11.48M	$ 0.00	$ 77.00K
Issuance Of Debt	$ 1.15M	$ 800.00K	$ -250.00K	$ 3.16M	$ 0.00	$ 895.00K
Repayment Of Debt	$ -360.15K	-	$ -250.00K	$ -810.00K	$ -229.47K	$ -113.14K
Free Cash Flow	$ -5.71M	$ -6.62M	$ -6.48M	$ -4.86M	$ 1.26M	$ -672.37K
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

INVO Bioscience Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing